Acadia Healthcare
Forecast impact
Track in portfolio
Price chart
Description
Company and Business Model
Acadia Healthcare operates in the healthcare sector, specializing in the provision of behavioral health services. The company primarily focuses on inpatient psychiatric care, residential treatment, and outpatient services. Its major business segments include acute care hospitals and outpatient facilities, with revenue generated mainly from patient services. Acadia Healthcare aims to address mental health issues through a range of treatment programs tailored to various patient needs.
Investment Profile
The investment profile of Acadia Healthcare suggests it may be more aligned with value investors, given its current financial metrics and market position. The stock exhibits characteristics that may appeal to those seeking stability rather than aggressive growth. The investment horizon could be medium-term, considering the company's operational challenges and market conditions. Liquidity is moderate, suitable for investors with basic experience in the healthcare sector.
Fundamental metrics (experimental) Updated: 2026-07-26
- EPS (TTM) — earnings per share for the last 12 months, $
- -12.24
- Revenue QoQ — quarter-over-quarter revenue growth
- 0.9%
- EPS surprise
- 32.1%
- 20d volatility
- 2.2%
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-07-27 | Buy | Hold | Weak fundamentals offset by strong recent price momentum. |
| 2026-07-20 | Hold | Buy | Strong momentum, but fundamentals show significant weakness. |
| 2026-06-19 | Sell | Hold | Strong momentum but significant EPS loss raises concerns. |
| 2026-06-11 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-24 | Sell | Hold | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-16 | Hold | Sell | Weak fundamentals and high volatility raise concerns. |
| 2026-05-08 | — | Hold | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-03 | Sell | Hold | Компания демонстрирует значительный рост за последние 60 дней, однако отрицательный EPS и высокая волатильность могут указывать на риски. Рекомендуется удерживать акции до более ясных сигналов для покупки. |
| 2026-05-01 | Hold | Sell | Компания демонстрирует значительные колебания цен и отрицательный EPS, что указывает на финансовые проблемы. Недавнее падение цены на 8.35% также свидетельствует о высоком уровне риска. |
| 2026-03-29 | Hold | Sell | Компания демонстрирует высокую волатильность и негативные показатели EPS, что указывает на риски. Однако недавний рост за 60 дней может свидетельствовать о потенциальном восстановлении. |
| 2026-02-12 | — | Hold | Компания Acadia Healthcare показывает значительный рост за последние 5 и 20 дней, что может указывать на восстановление. Однако, стоит учитывать высокую волатильность и падение на более длительных периодах. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-20 | Guggenheim | Target Raised | 31 → 38 | 34.5 |
| 2026-07-14 | KeyBanc | Target Raised | 30 → 40 | 30.56 |
| 2026-07-09 | UBS | Target Raised | 31 → 39 | 32.2206 |
| 2026-06-03 | Jefferies | Update | — → 30 | 24.42 |
| 2026-05-27 | KeyBanc | Update | — → 30 | 23.49 |
| 2026-05-04 | RBC Capital | Target Raised | 28 → 31 | 29.75 |
| 2026-05-04 | Guggenheim | Target Raised | 26 → 31 | 27.85 |
| 2026-05-01 | Cantor Fitzgerald | Target Raised | 20 → 30 | 26.3251 |
| 2026-04-30 | Barclays | Target Raised | 20 → 25 | 28.26 |
| 2026-04-20 | Jefferies | Target Raised | 20 → 24.5 | 27.5589 |
| 2026-04-17 | UBS | Target Raised | 27 → 31 | 27.4052 |
| 2026-02-26 | Raymond James | Update | — → 25 | 21.585 |
| 2026-02-26 | Leerink Partners | Target Raised | — → 22 | 20.84 |
| 2026-02-23 | Guggenheim | Target Lowered | 27 → 22 | 16.79 |
| 2026-01-22 | Jefferies | Update | — → 15 | 14.33 |
| 2026-01-14 | RBC Capital | Target Lowered | 19 → 17 | 12.36 |
| 2025-12-18 | Mizuho Securities | Target Lowered | 22 → 17 | 14.53 |
| 2025-12-04 | Barclays | Target Lowered | 17 → 14 | 14.69 |
| 2025-12-03 | RBC Capital | Target Lowered | 22 → 19 | 14.1405 |
News Page 1 of 1
Nothing yet